According to our (Global Info Research) latest study, the global Esomeprazole Capsule market size was valued at US$ 2727 million in 2025 and is forecast to a readjusted size of US$ 4041 million by 2032 with a CAGR of 5.8% during review period.
In 2025, global Esomeprazole Capsule production reached approximately 6309.52 million units, with an average global market price of around US$0.42 per capsule.
The gross profit margin of major companies in the industry is between 55%–75%.
In 2025, the global production capacity of esomeprazole capsules was approximately 8412.69 million units.
Esomeprazole Capsules are oral proton pump inhibitor formulations used to suppress gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme in gastric parietal cells. They are widely prescribed for the treatment of gastroesophageal reflux disease, peptic ulcer disease, erosive esophagitis, and Helicobacter pylori eradication therapy.
The industrial chain of Esomeprazole Capsules includes upstream active pharmaceutical ingredients, excipients, capsule shells, and packaging materials. The midstream focuses on formulation development, granulation, encapsulation, coating, and quality control. Downstream applications cover hospital prescriptions, retail pharmacies, and outpatient treatment settings, supported by regulatory compliance, distribution, and pharmacovigilance services.
The esomeprazole capsule market is supported by stable demand for acid-related disorder treatments. As a widely used proton pump inhibitor, esomeprazole remains a first-line therapy for GERD and peptic ulcer disease. Growth is driven by aging populations, increasing gastrointestinal disease prevalence, and continued use of generic formulations. Price competition is intense in mature markets, while volume growth remains stable. Overall, the market is expected to grow moderately with demand centered on large-volume, cost-effective generic production.
This report is a detailed and comprehensive analysis for global Esomeprazole Capsule market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Esomeprazole Capsule market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esomeprazole Capsule market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esomeprazole Capsule market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esomeprazole Capsule market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Esomeprazole Capsule
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Esomeprazole Capsule market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi, Mepha, Saval Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Esomeprazole Capsule market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Short-Term Use
Long-Term Use
Market segment by Release Profile
Immediate-Release Capsule
Enteric-Coated Capsule
Modified-Release Capsule
Market segment by Market Type
Originator Drug
Generic Drug
Hospital Use Capsule
Market segment by Application
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Major players covered
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Esomeprazole Capsule product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Esomeprazole Capsule, with price, sales quantity, revenue, and global market share of Esomeprazole Capsule from 2021 to 2026.
Chapter 3, the Esomeprazole Capsule competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Esomeprazole Capsule breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Esomeprazole Capsule market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Esomeprazole Capsule.
Chapter 14 and 15, to describe Esomeprazole Capsule sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Esomeprazole Capsule. Industry analysis & Market Report on Esomeprazole Capsule is a syndicated market report, published as Global Esomeprazole Capsule Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Esomeprazole Capsule market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.